This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Women With Cancer: An Exercise Study to Promote Health

This study has been completed.
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Yale University Identifier:
First received: January 19, 2010
Last updated: June 30, 2015
Last verified: June 2015
The purpose of the study is to evaluate the effect of an aerobic-resistance exercise program compared to a home based physical activity program on bone mass, body composition, metabolic risk factors and cardiovascular fitness in women with cancer who have completed therapy.

Condition Intervention
Bone Loss Cancer Behavioral: aerobic resistance exercise Behavioral: home based health promotion

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Supportive Care
Official Title: An Exercise Intervention to Improve Health in Postmenopausal Cancer Survivors

Resource links provided by NLM:

Further study details as provided by Yale University:

Primary Outcome Measures:
  • Bone mass-lumbar spine and hip (DEXA) [ Time Frame: baseline, 12 months ]
    Serum biomarkers for bone (serum NTX and serum osteocalcin) will be drawn at baseline, 6 and 12 months. Bone mass for lumbar spine and hip will be measured by DEXA scan at baseline and 12 months.

Secondary Outcome Measures:
  • body composition-% fat mass, % lean muscle mass (whole body DEXA) [ Time Frame: baseline, 6, 12 months ]
    Body composition will be assessed by waist circumference and whole body DEXA scan (% fat mass, % lean muscle mass) at baseline, 6 and 12 months

Enrollment: 154
Study Start Date: January 2008
Study Completion Date: March 2013
Primary Completion Date: March 2013 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: aerobic resistance
12 month aerobic resistance exercise at a fitness center
Behavioral: aerobic resistance exercise
three times per week aerobic resistance exercise for 12 months
Other Name: physical activity
Active Comparator: home based physical activity
national recommendations for physical activity for adults
Behavioral: home based health promotion
education and support to adapt national guidelines for 30 minutes physical activity most days of the week
Other Name: health promotion

Detailed Description:
The proposed study will evaluate an endurance-resistive exercise intervention to attenuate the effects of menopause and cancer treatment (bone loss, increased body fat, decreased lean muscle mass, weight gain, decreased physical activity) in an at-risk population of female cancer survivors. Women with solid tumors (breast, gynecological, colo-rectal) and lymphoma who have completed primary and/or adjuvant therapy within the past three years and who are perimenopausal or early postmenopausal and any woman on an Aromatase Inhibitor will be recruited to participate in a randomized controlled trial (RCT) of a 12 month exercise intervention (N=75) versus a health promotion control group (N=75). The specific aims of the study are to: (1) examine the effects of an exercise intervention on bone mass (serum biomarkers, lumbar spine, hip DEXA) and body composition (whole body DEXA, weight, waist circumference), (2) examine the effect of an exercise intervention on metabolic risk factors (lipids, cholesterol, fasting glucose, insulin resistance, Hemoglobin A1-C, and blood pressure), and (3) examine the effects of an exercise intervention on functional status and cardiovascular fitness (exercise stress test).

Ages Eligible for Study:   18 Years to 75 Years   (Adult, Senior)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Female
  • Cancer diagnosis
  • Postmenopausal

Exclusion Criteria:

  • Health condition contraindication to moderate physical activity
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01102985

United States, Connecticut
Yale University
New Haven, Connecticut, United States, 06536-0740
Sponsors and Collaborators
Yale University
National Cancer Institute (NCI)
Principal Investigator: M. Tish Knobf, PhD Yale University
  More Information

Responsible Party: Yale University Identifier: NCT01102985     History of Changes
Other Study ID Numbers: 0801003383
1R01CA122658-01A2 ( U.S. NIH Grant/Contract )
Study First Received: January 19, 2010
Last Updated: June 30, 2015

Keywords provided by Yale University:
physical activity
cancer survivor processed this record on September 19, 2017